Status:

TERMINATED

Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

Massachusetts General Hospital

Conditions:

Elderly

Eligibility:

All Genders

65-85 years

Phase:

PHASE2

Brief Summary

The purpose of the study is to evaluate the effect of a naturally occurring hormone, called Growth Hormone Releasing Hormone (GHRH), on the muscle, bone and fat tissues of the body. GHRH stimulates th...

Detailed Description

Growth hormone (GH) is a major anabolic hormone that exerts important stimulatory effects on protein synthesis. Many of the peripheral tissue effects of GH are mediated by insulin-like growth factor I...

Eligibility Criteria

Inclusion

  • Documentation of low GH levels as assessed by a fasting IGF-1 level \<135ng/ml.
  • Volunteers whose BMI is above normal range and below extreme obesity (BMI 25-40 kg/m2).

Exclusion

  • Diabetes.
  • Known coronary artery disease.
  • Liver, peptic or inflammatory bowel disease. Renal or hematologic disease.
  • Hematocrit \<30% or \>50%.
  • Clinically significant prostate hypertrophy.
  • Elevated Prostate specific antigen (PSA) (4ng/ml).
  • Prostate \& breast cancer.
  • History of malignancy \<5 years other than basal cell of the skin.
  • Chronic pulmonary disease or other systemic disorders.
  • Use of certain drugs (such as thiazide diuretics, beta-blockers, steroids (except for replacement doses), coumadin, and or androgen supplements).
  • Peanut allergy.
  • Gross physical impairment.
  • Sleep apnea.
  • Uncontrolled hypertension(blood pressure \>160/95 and or requiring more than two antihypertensive medications).
  • A clinically worrisome mammogram in women.
  • Exercise training (\>2x/wk for 20 min at a level that produces sweating) in the last 6 months.

Key Trial Info

Start Date :

December 17 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 29 2010

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT00807365

Start Date

December 17 2007

End Date

April 29 2010

Last Update

April 27 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, United States, 21224

2

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114